Thanks Nuts.
You sure have a good handle on this scientific stuff. Must have actually listened during Biology class (unlike myself).
As you say ONT-10 looks about 3-4 years behind, given they just started Phase 1 trial in March this year.
Merck might be somewhat peeved that this may well eventually supercede or surpass Stimuvax. Guess they'll just have to pony up some more development funds to keep their hand in.
ONTY's CEO just announced a few days ago that they'll be releasing the Stimuvax trial efficacy data "1st Qtr 2013" so should be interesting, given this was delayed a while back. Just shows you, everyone hits bumps in the road along the way.
Cheers
K
watch this space, page-7
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $421.2M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 28.0¢ | $2.100M | 7.109M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 233293 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 36945 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |